Eric L. Nuermberger
Center for Tuberculosis Research
Department of Medicine
Johns Hopkins University School of Medicine
1550 Orleans St.
Name/email consistency: high
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis. Tasneen, R., Li, S.Y., Peloquin, C.A., Taylor, D., Williams, K.N., Andries, K., Mdluli, K.E., Nuermberger, E.L. Antimicrob. Agents Chemother. (2011)
- Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis. Nuermberger, E., Tyagi, S., Tasneen, R., Williams, K.N., Almeida, D., Rosenthal, I., Grosset, J.H. Antimicrob. Agents Chemother. (2008)
- Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis. Nuermberger, E., Rosenthal, I., Tyagi, S., Williams, K.N., Almeida, D., Peloquin, C.A., Bishai, W.R., Grosset, J.H. Antimicrob. Agents Chemother. (2006)
- Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model. Nuermberger, E., Tyagi, S., Williams, K.N., Rosenthal, I., Bishai, W.R., Grosset, J.H. Am. J. Respir. Crit. Care Med. (2005)
- Low-dose aerosol model of pneumococcal pneumonia in the mouse: utility for evaluation of antimicrobial efficacy. Nuermberger, E., Helke, K., Bishai, W.R. Int. J. Antimicrob. Agents (2005)
- Murine models of pneumococcal pneumonia and their applicability to the study of tissue-directed antimicrobials. Nuermberger, E. Pharmacotherapy (2005)
- The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Nuermberger, E., Bishai, W.R. Clin. Infect. Dis. (2004)
- Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. Nuermberger, E.L., Yoshimatsu, T., Tyagi, S., Williams, K., Rosenthal, I., O'Brien, R.J., Vernon, A.A., Chaisson, R.E., Bishai, W.R., Grosset, J.H. Am. J. Respir. Crit. Care Med. (2004)